Researchers of Grattoni lab have developed a nanodevice that administers immunotherapy drugs directly into pancreatic ductal adenocarcinomas. Read more on Leading Medicine: spr.ly/6017nkGvc

Check out our latest work on drug biodistribution in the tumor when delivered via a sustained intratumoral delivery implant.

We are excited about this collaboration and the potential end product and its impact on HIV and pregnancy prevention. #leadinginnovation Houston Methodist MD

Thank you CRS Malaysia Local Chapter (MyCRS) for the opportunity to share our work at the MyCRS Young Scientist symposium organized by the Malaysian chapter of Controlled Release Society. #MyCRSYSS2023 It was nice meeting local scientists. I look forward to the symposium next year!

Day 2 of #MyCRSYSS2023 CRS Malaysia Local Chapter (MyCRS) with plenary talk from Dr Corrine Grattoni lab #Houston

Captivated by Dr. Corrine's talk this morning! Grattoni lab

Had a fireside chat with Maurizio Reggiani VP of @lamborghini about carbon fiber materials and space exploration. Thank you Patrick O’Neill ISS National Lab for moderating a fun session at #ISSRDC2023 . Looking forward to our next Space experiment! Houston Methodist MD Houston Methodist

Had a fireside chat with Maurizio Reggiani VP of @lamborghini about carbon fiber materials and space exploration. Thank you Patrick O’Neill ISS National Lab for moderating a fun session at #ISSRDC2023 . Looking forward to our next Space experiment! Houston Methodist MD Houston Methodist

Please join us at the Controlled Release Society Bioengineering session tomorrow where Dr. Grattoni will share our recent work. #CRS2023

Please join us at #ISSRDC 2023 where we will be sharing our recent work in space performed in collaboration with Lamborghini. #leadinginnovation Houston Methodist MD Houston Methodist

Sharing our recent publication in Science Translational Medicine on a long acting implant for HIV PrEP that can deliver islatravir antiretroviral continuously for 20 months at a time. Thanks to our collaborators and funding from @nih NIAID News. Houston Methodist MD Houston Methodist Gates Foundation Merck

Love space?🚀🌟

You a biologist, programmer, physician, modeler, bioinformatician?

Wouldn’t it be interesting for your lab w/collaborators to meta-analyze #AI #ML model w/space biomedical data? 🧮

Here’s a🧵bundle of new #OpenScience datasets in osdr.nasa.gov

1/8

Great news! We're thrilled to announce the addition of Assist. Prof. Dr. Corrine Chua from @grattonilab as our plenary speaker for #MyCRSYSS2023 . Register now at tinyurl.com/mvrze5zx & visit crsmalaysia.wixsite.com/mycrs-symposium for more information.

Nikitha Kota recently presented her work on the NanoLymph cell recruitment platform at the 2023 NYAS Frontiers in Cancer Immunotherapy in New York City. She met with leaders in field of cancer immunotherapy. We are lucky to have young scientists like her in the lab!

We look forward to sharing our work on Bioengineering at #CRS2023 on July 23. Houston Methodist MD Houston Methodist

Our most recent publication is featured as a cover in Advanced Science: onlinelibrary.wiley.com/doi/10.1002/ad… This paper on intratumoral implant for pancreatic cancer treatment is the fruition of a collaboration between Drs. Shuhsia Chen, Chua and Grattoni. Houston Methodist MD Houston Methodist

Thank you for sharing our work! We hope that the increased visibility could expedite our goal of bringing the technology to the clinic sooner to help those in need.
Houston Methodist MD Houston Methodist

.Gorka Orive, Grattoni lab, board member Bob Langer, and colleagues review emerging immunomodulatory strategies for cell therapeutics: cell.com/trends/biotech…